This argument is hard to buy when pharma has been turning 20% profits in the US for decades, far and away above any industry. Boohoo, compliance is obviously so

This argument is hard to buy when pharma has been turning 20% profits in the US for decades, far and away above any industry. Boohoo, compliance is obviously so onerous for them, wah.